4.5 Review

Somatostatin and dopamine receptors as targets for medical treatment of Cushing's Syndrome

Related references

Note: Only part of the references are listed.
Article Endocrinology & Metabolism

Use of cabergoline in persisting Cushing's disease

F. Illouz et al.

ANNALES D ENDOCRINOLOGIE (2006)

Article Endocrinology & Metabolism

Effect of cabergoline treatment on Cushing's disease caused by aberrant adrenocorticotropin-secreting macroadenoma

T Miyoshi et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2004)

Article Endocrinology & Metabolism

Is there a therapeutic role for octreotide in patients with ectopic Cushing's syndrome?

GL Uwaifo et al.

JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION (2003)